PASG · NASDAQ · Biotechnology

Passage Bio (PASG)

Winding down neurodegenerative gene therapies while pursuing a merger with Remix Therapeutics.

$5.00
vs last close+0.05 (+1.01%)

Something off on this page? Send us feedback.

Next report
Nov 9, 26
in 47 days
EPS estimate
−$2.44
Revenue estimate
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$4.00−$5.00−$2.96−$2.44−$4.08−$2.36−$2.44Pending
Estimate−$0.23−$4.60−$4.00−$2.76−$2.19−$2.15−$2.27−$2.44
Surprise−1,677.8%−8.7%+26.0%+11.5%−86.3%−9.8%−7.5%

RevenueReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
ReportedPending
Estimate
Surprise

HistoryUpcoming

Date / PeriodEstimateReportedSurprise
Dec 2026−$2.55
Nov 2026−$2.44
Aug 2026−$2.27−$2.44−7.5%
May 2026−$2.15−$2.36−9.8%
Mar 2026−$2.19−$4.08−86.3%
Nov 2025−$2.76−$2.44+11.5%
Aug 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Mar 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Nov 2022
Aug 2022
May 2022
Mar 2022
Nov 2021
Aug 2021
May 2021
Mar 2021
Nov 2020
Aug 2020
May 2020
Feb 2020
Dec 2019
Jun 2019
Mar 2019
Dec 2018

The latest year is open to everyone — the 27 quarters behind it read with an account.

Date / PeriodEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Dec 2026−$2.55$0
Nov 9, 2026−$2.44$0
Aug 10, 2026−$2.27−$2.44−7.5%−1.8%
May 12, 2026−$2.15−$2.36−9.8%+14.3%
Mar 3, 2026−$2.19−$4.08−86.3%−8.9%
Nov 10, 2025−$2.76−$2.44+11.5%+6.7%
Aug 12, 2025
May 13, 2025
Mar 4, 2025
Nov 13, 2024
Aug 8, 2024
May 13, 2024
Mar 4, 2024
Nov 13, 2023
Aug 7, 2023
May 11, 2023
Mar 6, 2023
Nov 10, 2022
Aug 4, 2022
May 16, 2022
Mar 3, 2022
Nov 4, 2021
Aug 5, 2021
May 5, 2021
Mar 3, 2021
Nov 10, 2020
Aug 13, 2020
May 11, 2020
Feb 28, 2020
Dec 31, 2019
Jun 30, 2019
Mar 31, 2019
Dec 31, 2018

The latest year is open to everyone — the 27 quarters behind it read with an account.